Elitza S. Theel

8.3k total citations · 4 hit papers
110 papers, 3.6k citations indexed

About

Elitza S. Theel is a scholar working on Infectious Diseases, Epidemiology and Parasitology. According to data from OpenAlex, Elitza S. Theel has authored 110 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Infectious Diseases, 41 papers in Epidemiology and 26 papers in Parasitology. Recurrent topics in Elitza S. Theel's work include SARS-CoV-2 and COVID-19 Research (31 papers), SARS-CoV-2 detection and testing (20 papers) and Viral Infections and Vectors (19 papers). Elitza S. Theel is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (31 papers), SARS-CoV-2 detection and testing (20 papers) and Viral Infections and Vectors (19 papers). Elitza S. Theel collaborates with scholars based in United States, Switzerland and Brazil. Elitza S. Theel's co-authors include Robin Patel, Matthew J. Binnicker, Bobbi S. Pritt, Christopher D. Doern, Dane Granger, Julie Harring, Nancy L. Wengenack, Heather Hilgart, Marc Roger Couturier and Leslie Hall and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Elitza S. Theel

102 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization

2021 448 citations Rita E. Chen, Elitza S. Theel et al. profile →
A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiologya

2018 350 citations Sheldon Campbell, Robin Patel et al. profile →
A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiologya

2018 323 citations Sheldon Campbell, Robin Patel et al. profile →
Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)

2024 62 citations Sheldon Campbell, Robin Patel et al. profile →

Peers

Elitza S. Theel

EPIDE

PHEOH

Matthew J. Binnicker United States

Pyoeng Gyun Choe South Korea

Katia Jaton Switzerland

Sook‐In Jung South Korea

Roberto Luzzati Italy

Lars F. Westblade United States

Yong Pil Chong South Korea

Joseph D. Yao United States

Randall T. Hayden United States

Olivier Vandenberg Belgium

Matthew J. Binnicker United States

Elitza S. Theel

1.7k ×0.8

1.7k ×1.5

EPIDE

404 ×0.8

PHEOH

420 ×1.0

284 ×0.8

Citations per year, relative to Elitza S. Theel Elitza S. Theel (= 1×) peers Matthew J. Binnicker

Countries citing papers authored by Elitza S. Theel

Since Specialization

Citations

This map shows the geographic impact of Elitza S. Theel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elitza S. Theel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elitza S. Theel more than expected).

Fields of papers citing papers by Elitza S. Theel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elitza S. Theel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elitza S. Theel. The network helps show where Elitza S. Theel may publish in the future.

Co-authorship network of co-authors of Elitza S. Theel

This figure shows the co-authorship network connecting the top 25 collaborators of Elitza S. Theel. A scholar is included among the top collaborators of Elitza S. Theel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elitza S. Theel. Elitza S. Theel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Theel, Elitza S., Julianne V. Kus, Thomas E. Grys, et al.. (2025). Practical Guidance for Clinical Microbiology Laboratories: Antibody and antigen detection methods for dimorphic fungal infections. Clinical Microbiology Reviews. 38(2). e0000520–e0000520.

Friedman, Daniel, Elitza S. Theel, Randall C. Walker, et al.. (2024). Serial Bronchoalveolar Lavage Fluid Aspergillus Galactomannan and Treatment Response in Invasive Pulmonary Aspergillosis. Open Forum Infectious Diseases. 11(4). ofae114–ofae114. 2 indexed citations

Schuetz, Audrey N., et al.. (2024). Testing for Helicobacter pylori in an era of antimicrobial resistance. Journal of Clinical Microbiology. 62(2). e0073223–e0073223. 11 indexed citations

Lobo, Ronstan, Laura De Michieli, Grant M. Spears, et al.. (2024). Serial high sensitivity troponin sampling in patients with SARS-CoV-2 infection. Clinical Biochemistry. 125. 110732–110732.

Grys, Thomas E., et al.. (2024). Whole-Blood PCR Preferred for Timely Diagnosis of Neuroinvasive West Nile Virus Infections: Lessons From the 2021 Arizona Outbreak. Open Forum Infectious Diseases. 11(5). ofae188–ofae188. 4 indexed citations

Silverberg, Jonathan I., Israel Zyskind, Hiam Naiditch, et al.. (2022). Predictors of chronic COVID-19 symptoms in a community-based cohort of adults. PLoS ONE. 17(8). e0271310–e0271310. 14 indexed citations

Khera, Rohan, Bobak J. Mortazavi, Veer Sangha, et al.. (2022). A multicenter evaluation of computable phenotyping approaches for SARS-CoV-2 infection and COVID-19 hospitalizations. npj Digital Medicine. 5(1). 27–27. 8 indexed citations

Ripoll, Juan G., Justin E. Juskewitch, Raymund R. Razonable, et al.. (2022). Vaccine-boosted convalescent plasma therapy for patients with immunosuppression and COVID-19. Blood Advances. 6(23). 5951–5955. 12 indexed citations

Chiarella, Sergio E., Sarah M. Jenkins, Carin Y. Smith, et al.. (2022). Predictors of seroconversion after coronavirus disease 2019 vaccination. Annals of Allergy Asthma & Immunology. 129(2). 189–193. 2 indexed citations

10.

Farnsworth, Christopher W, James Brett Case, Karl Hock, et al.. (2021). Assessment of serological assays for identifying high titer convalescent plasma. Transfusion. 61(9). 2658–2667. 10 indexed citations

11.

Peaper, David R., Daniel D. Rhoads, Kaede V. Sullivan, et al.. (2021). Considerations from the College of American Pathologists for Implementation of an Assay for SARS-CoV-2 Testing after a Change in Regulatory Status. Journal of Clinical Microbiology. 59(10). e0116721–e0116721. 6 indexed citations

12.

Sendi, Parham, Rossella Baldan, Peter Gowland, et al.. (2021). A Multidimensional Cross-Sectional Analysis of Coronavirus Disease 2019 Seroprevalence Among a Police Officer Cohort: The PoliCOV-19 Study. Open Forum Infectious Diseases. 8(12). ofab524–ofab524. 3 indexed citations

13.

Turgeon, Coleman, Piero Rinaldo, Dane Granger, et al.. (2021). Validation of a multiplex flow immunoassay for detection of IgG antibodies against SARS-CoV-2 in dried blood spots. PLoS ONE. 16(5). e0252621–e0252621. 9 indexed citations

14.

Reifert, Jack, Kathy Kamath, Ewa Lis, et al.. (2020). Serum Epitope Repertoire Analysis Enables Early Detection of Lyme Disease with Improved Sensitivity in an Expandable Multiplex Format. Journal of Clinical Microbiology. 59(2). 6 indexed citations

15.

Patel, Robin, Esther Babady, Elitza S. Theel, et al.. (2020). Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS–CoV-2/COVID-19. mBio. 11(2). 262 indexed citations

16.

Theel, Elitza S., Marc Roger Couturier, Laura Filkins, et al.. (2020). Application, Verification, and Implementation of SARS-CoV-2 Serologic Assays with Emergency Use Authorization. Journal of Clinical Microbiology. 59(1). 16 indexed citations

17.

Hashmi, Shahrukh K., M. Hassan Murad, & Elitza S. Theel. (2020). Screening for SARS-CoV-2. Mayo Clinic Proceedings. 95(12). 2606–2608. 2 indexed citations

18.

Miller, Halie K., Alison M. Binder, Amy Peterson, et al.. (2018). Trends in Q fever serologic testing by immunofluorescence from four large reference laboratories in the United States, 2012–2016. Scientific Reports. 8(1). 16670–16670. 11 indexed citations

19.

Ramanan, Poornima, Nancy L. Wengenack, & Elitza S. Theel. (2017). Laboratory Diagnostics for Fungal Infections. Clinics in Chest Medicine. 38(3). 535–554. 8 indexed citations

20.

Anderson, Neil W., Deborah J. Jespersen, Joseph Kubofcik, et al.. (2014). Comparison of Three Immunoassays for Detection of Antibodies to Strongyloides stercoralis. Clinical and Vaccine Immunology. 21(5). 732–736. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact